Clinical Trial: Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189455) titled 'Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer' on Sept. 16.

Brief Summary: The main objective is to compare ZG006 with Investigator-Selected Chemotherapy on prolonging overall survival (OS).

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Small-cell Lung Cancer

Intervention: DRUG: ZG006

ZG006 will be administered as an intravenous (IV) infusion.

DRUG: Topotecan

Topotecan will be administered per local standard of care

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Published by HT Digital Cont...